Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

• Main Authors: Mahmoud S. Alghamri (Author), Brandon L. McClellan (Author), Carson S. Hartlage (Author), Santiago Haase (Author), Syed Mohd Faisal (Author), Rohit Thalla (Author), Ali Dabaja (Author), Kaushik Banerjee (Author), Stephen V. Carney (Author), Anzar A. Mujeeb (Author), Michael R. Olin (Author), James J. Moon (Author), Anna Schwendeman (Author), Pedro R. Lowenstein (Author), Maria G. Castro (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...